Rodent models of amyotrophic lateral sclerosis

• Rodent models of ALS can be used to study the pathophysiology of ALS and trial therapeutics.
• SOD1, TDP-43, FUS and VCP rodent models of ALS are summarised.
• A brief overview of therapeutics recently trialled in rodent models of ALS is given.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by the degeneration of upper and lower motor neurons. Recent advances in our understanding of some of the genetic causes of ALS, such as mutations in SOD1, TARDBP, FUS and VCP have led to the generation of rodent models of the disease, as a strategy to help our understanding of the pathophysiology of ALS and to assist in the development of therapeutic strategies. This review provides detailed descriptions of TDP-43, FUS and VCP models of ALS, and summarises potential therapeutics which have been recently trialled in rodent models of the disease. This article is part of a Special Issue entitled: Animal Models of Disease.